Ferring Pharmaceuticals, Inc.
Investigation of PICOPREP and PEG-ELS for Bowel Preparation for Colonoscopy
- First Posted Date
- 2011-05-19
- Last Posted Date
- 2013-01-28
- Lead Sponsor
- Ferring Pharmaceuticals
- Target Recruit Count
- 300
- Registration Number
- NCT01356407
- Locations
- 🇨🇳
Nanfang Hospital, Southern Medical University, Guangzhou, China
🇨🇳The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China
🇨🇳Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China
Assessment of the Effectiveness of Menopur in Intrauterine Insemination
- First Posted Date
- 2011-05-17
- Last Posted Date
- 2025-03-28
- Lead Sponsor
- Ferring Pharmaceuticals
- Target Recruit Count
- 207
- Registration Number
- NCT01354834
- Locations
- 🇪🇸
Investigational site, Valladolid, Spain
Adipocyte Function and Somtropin Deficiency
- First Posted Date
- 2011-05-11
- Last Posted Date
- 2011-05-11
- Lead Sponsor
- Ferring Pharmaceuticals
- Target Recruit Count
- 62
- Registration Number
- NCT01351818
- Locations
- 🇪🇸
Investigational site, Tenerife, Spain
Follow-up of Glypressin (Terlipressin) Clinical Efficacy in the Treatment of Bleeding Oesophageal Varices
- Conditions
- Gastrointestinal BleedingOesophageal Varices
- First Posted Date
- 2011-04-14
- Last Posted Date
- 2012-10-08
- Lead Sponsor
- Ferring Pharmaceuticals
- Target Recruit Count
- 20
- Registration Number
- NCT01335516
- Locations
- 🇷🇴
Emergency County Hospital - Surgery Clinic No.1, Târgu Mureş, Mureş, Romania
Investigation of KLYX in Patients With Constipation
- First Posted Date
- 2011-04-14
- Last Posted Date
- 2012-02-06
- Lead Sponsor
- Ferring Pharmaceuticals
- Target Recruit Count
- 60
- Registration Number
- NCT01335386
- Locations
- 🇨🇳
Changhai Hospital, The Second Military Medical University, Shanghai, China
🇨🇳Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China
🇨🇳Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China
Assessment of the Effectiveness and Tolerability of Ovarian Hyperstimulation
- Conditions
- STERILITY
- Interventions
- Drug: hMG-HP
- First Posted Date
- 2011-04-08
- Last Posted Date
- 2011-04-08
- Lead Sponsor
- Ferring Pharmaceuticals
- Target Recruit Count
- 279
- Registration Number
- NCT01331720
- Locations
- 🇪🇸
Investigational site, Zaragoza, Spain
🇪🇸Investigational site Sta. Cruz, Tenerife, Spain
Comparative Assessment of the Clinical Utility of Ovarian Stimulation With Menotropin Versus Menotropin Plus GnRH Antagonist
- First Posted Date
- 2011-04-08
- Last Posted Date
- 2011-04-08
- Lead Sponsor
- Ferring Pharmaceuticals
- Target Recruit Count
- 131
- Registration Number
- NCT01331733
- Locations
- 🇪🇸
Investigational site, Valladolid, Spain
Assessment of the Therapeutic Utility of hMG-HP
- Conditions
- Sterility
- Interventions
- Drug: hMG-HP
- First Posted Date
- 2011-04-07
- Last Posted Date
- 2011-04-07
- Lead Sponsor
- Ferring Pharmaceuticals
- Target Recruit Count
- 61
- Registration Number
- NCT01330784
- Locations
- 🇪🇸
Investigational site, Valencia, Spain
Assessment of the Therapeutic Utility of r-FSH in Association With hMG-HP
- Conditions
- Sterility
- Interventions
- Drug: hMG-HP/r-FSH
- First Posted Date
- 2011-04-07
- Last Posted Date
- 2011-04-07
- Lead Sponsor
- Ferring Pharmaceuticals
- Target Recruit Count
- 51
- Registration Number
- NCT01330771
- Locations
- 🇪🇸
Investigational site, Valencia, Spain
Evaluation of Overall Compliance and Duration of Zomacton® Treatment With the Zomajet® Needle-free Device
- First Posted Date
- 2011-03-01
- Last Posted Date
- 2023-11-18
- Lead Sponsor
- Ferring Pharmaceuticals
- Target Recruit Count
- 87
- Registration Number
- NCT01306357
- Locations
- 🇫🇷
Investigational site, Toulouse, France